Activated fibroblasts in cancer: Perspectives and challenges
G Caligiuri, DA Tuveson - Cancer cell, 2023 - cell.com
Activated fibroblasts in tumors, or cancer-associated fibroblasts (CAFs), have become a
popular research area over the past decade. As important players in many aspects of tumor …
popular research area over the past decade. As important players in many aspects of tumor …
[HTML][HTML] Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche
G Dong, P Chen, Y Xu, T Liu, R Yin - Cancer Letters, 2023 - Elsevier
Cancer-associated fibroblasts (CAFs) are abundant and important components of the
tumour mesenchyme, and have been extensively studied for their role in primary tumours …
tumour mesenchyme, and have been extensively studied for their role in primary tumours …
Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a …
Background The prognostic management of bladder cancer (BLCA) remains a great
challenge for clinicians. Recently, bulk RNA-seq sequencing data have been used as a …
challenge for clinicians. Recently, bulk RNA-seq sequencing data have been used as a …
Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors
LG Sousa, DJ McGrail, F Lazar Neto, K Li… - Clinical Cancer …, 2023 - AACR
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma
K Okuyama, T Naruse, S Yanamoto - Journal of Experimental & Clinical …, 2023 - Springer
Current clinical and observational evidence supports the EXTREME regimen as one of the
standards of care for patients with recurrent or metastatic head and neck squamous cell …
standards of care for patients with recurrent or metastatic head and neck squamous cell …
[PDF][PDF] Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
Due to their immunosuppressive role, tumor-infiltrating regulatory T cells (TI-Tregs)
represent attractive immuno-oncology targets. Analysis of TI vs. peripheral Tregs (P-Tregs) …
represent attractive immuno-oncology targets. Analysis of TI vs. peripheral Tregs (P-Tregs) …
[HTML][HTML] Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
S Guo, J Yuan, X Meng, X Feng, D Ma, Y Han… - International …, 2023 - Elsevier
The tumour microenvironment (TME) is critical for the initiation, progression, and metastasis
of tumours, and cancer-associated fibroblasts (CAFs) are the most dominant cells and have …
of tumours, and cancer-associated fibroblasts (CAFs) are the most dominant cells and have …
Curcumin and analogues against head and neck cancer: from drug delivery to molecular mechanisms
C Zhao, X Zhou, Z Cao, L Ye, Y Cao, J Pan - Phytomedicine, 2023 - Elsevier
Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most life-
threatening diseases which also causes economic burden worldwide. To overcome the …
threatening diseases which also causes economic burden worldwide. To overcome the …
[HTML][HTML] Dissecting the functions of cancer-associated fibroblasts to therapeutically target head and neck cancer microenvironment
L Prieto-Fernández, I Montoro-Jiménez… - Biomedicine & …, 2023 - Elsevier
Head and neck cancers (HNC) are a diverse group of aggressive malignancies with high
morbidity and mortality, leading to almost half-million deaths annually worldwide. A better …
morbidity and mortality, leading to almost half-million deaths annually worldwide. A better …
Precision immunotherapy
A Obradovic - Science, 2023 - science.org
In the past decade, cancer treatment has been revolutionized by the rise of checkpoint
inhibitor immunotherapies. Traditional approaches to treating cancer have been focused on …
inhibitor immunotherapies. Traditional approaches to treating cancer have been focused on …